Last reviewed · How we verify

Anesthetics, Inhalation

Dr. John A. Thiel Medical Professional Corporation · Phase 2 active Small molecule

Anesthetics, Inhalation is a Anesthetics, Inhalation Small molecule drug developed by Dr. John A. Thiel Medical Professional Corporation. It is currently in Phase 2 development for General anesthesia induction and maintenance during surgical procedures. Also known as: Methoxyflurane.

Inhalation anesthetics work by depressing the central nervous system to induce unconsciousness and analgesia.

Inhalation anesthetics work by depressing the central nervous system to induce unconsciousness and analgesia. Used for General anesthesia induction and maintenance during surgical procedures.

Likelihood of approval
15.3% vs 15.3% industry baseline
If approved by FDA: likely 2031–2034
Steps remaining: Phase 3 → NDA/BLA submission
Confidence: Medium
Why this estimate
  • Baseline phase 2 → approval rate +15.3pp
    Industry-wide phase 2 drugs reach approval ~15.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
Predicted approval windows by jurisdiction (conditional on FDA approval)
Regulator Country Likely year Lag vs FDA
FDA US 2031–2034
EMA EU 2032–2035 +0.7 yr
MHRA GB 2032–2035 +0.7 yr
Health Canada CA 2032–2036 +0.9 yr
TGA AU 2032–2036 +1.2 yr
PMDA JP 2032–2036 +1.5 yr
NMPA CN 2033–2037 +2.3 yr
MFDS KR 2032–2036 +1.4 yr
CDSCO IN 2032–2037 +1.8 yr
ANVISA BR 2033–2037 +2.3 yr

Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).

Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.

At a glance

Generic nameAnesthetics, Inhalation
Also known asMethoxyflurane
SponsorDr. John A. Thiel Medical Professional Corporation
Drug classAnesthetics, Inhalation
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhasePhase 2

Mechanism of action

These agents typically act on various receptors and ion channels in the brain to reduce neuronal excitability, leading to a state of general anesthesia.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Anesthetics, Inhalation

What is Anesthetics, Inhalation?

Anesthetics, Inhalation is a Anesthetics, Inhalation drug developed by Dr. John A. Thiel Medical Professional Corporation, indicated for General anesthesia induction and maintenance during surgical procedures.

How does Anesthetics, Inhalation work?

Inhalation anesthetics work by depressing the central nervous system to induce unconsciousness and analgesia.

What is Anesthetics, Inhalation used for?

Anesthetics, Inhalation is indicated for General anesthesia induction and maintenance during surgical procedures.

Who makes Anesthetics, Inhalation?

Anesthetics, Inhalation is developed by Dr. John A. Thiel Medical Professional Corporation (see full Dr. John A. Thiel Medical Professional Corporation pipeline at /company/dr-john-a-thiel-medical-professional-corporation).

Is Anesthetics, Inhalation also known as anything else?

Anesthetics, Inhalation is also known as Methoxyflurane.

What drug class is Anesthetics, Inhalation in?

Anesthetics, Inhalation belongs to the Anesthetics, Inhalation class. See all Anesthetics, Inhalation drugs at /class/anesthetics-inhalation.

What development phase is Anesthetics, Inhalation in?

Anesthetics, Inhalation is in Phase 2.

What are the side effects of Anesthetics, Inhalation?

Common side effects of Anesthetics, Inhalation include Nausea and vomiting.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing